Investors Mutual’s Daniel Moore says there aren’t too many ASX-listed companies like blood plasma giant CSL that can compound ...

The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...

Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.

The top-of-the-line BMW M4 CS gets an improved chassis and is powered by a 3.0-litre twin-turbo straight-six engine tuned to ...

The new BMW M4 Competition Sport is the more focused iteration and doubles down on the hardcore quotient with a host of ...

RALEIGH, N.C. (WNCN) — The N.C. Chamber has revealed the winners for this year’s Coolest Thing Made in NC competition. The ...

Biofund IV raised EUR 140 million in first closing of EUR 250 million fundBiofund IV to follow Kurma’s proven investment strategy and make 16 to 20 new investmentsFirst three investments of the new ...

AFIC has been actively buying these stocks. The post These are the ASX blue-chip shares this big Aussie fund has been buying ...

Tech unicorn Atlassian reported $200 million in research and development expenditure in 2021-2022, topping the inaugural ATO ...

With the ASX at all time highs, Wilson Asset Management's Matthew Haupt shares where he is finding value right now.

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks ...